CK1δ as a potential therapeutic target to treat bladder cancer

Bladder cancer is the second most common genitourinary malignancy in the world. However, only immune-checkpoint inhibitors and erdafitinib are available to treat advanced bladder cancer. Our previous study reported that 4-((4-(4-ethylpiperazin-1-yl) phenyl)amino)-N-(3,4,5-trichlorophenyl)-7H-pyrrolo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Aging (Albany NY)
Hlavní autoři: Lin, Yu-Chen, Chen, Mei-Chuan, Hsieh, Tsung-Han, Liou, Jing-Ping, Chen, Chun-Han
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals 2020
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7185098/
https://ncbi.nlm.nih.gov/pubmed/32282334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.102966
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky